In leukemia, Hyle et al. showed that CTCF depleting results in loss of MYC expression by disrupted MYC promotor-enhancer interaction in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) [33]. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.